Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daxor Corp (DE:DX5)
FRANKFURT:DX5
Daxor (DX5) Stock Price & Analysis
1 Followers
DX5 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€6.45 - €11.90
Previous Close€9
Volume0.00
Average Volume (3M)254.00
Market Cap
€43.08M
Enterprise Value€44.22M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$1.23M
Price to Earnings (P/E)N/A
Beta0.02
Next Earnings
Aug 22, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jan 05, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,196,182
10 Day Avg. Volume47
30 Day Avg. Volume254
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)1.42
Price to Sales (P/S)5.92
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€21.59Price Target Upside142.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Daxor News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
DX5 FAQ
What was Daxor Corp’s price range in the past 12 months?
Daxor Corp lowest stock price was €6.45 and its highest was €11.90 in the past 12 months.
What is Daxor Corp’s market cap?
Currently, no data Available
When is Daxor Corp’s upcoming earnings report date?
Daxor Corp’s upcoming earnings report date is Aug 22, 2024 which is in 107 days.
How were Daxor Corp’s earnings last quarter?
Daxor Corp released its earnings results on Mar 18, 2024. The company reported €0.641 earnings per share for the quarter, beating the consensus estimate of N/A by €0.641.
Is Daxor Corp overvalued?
According to Wall Street analysts Daxor Corp’s price is currently Undervalued.
Does Daxor Corp pay dividends?
Daxor Corp pays a Notavailable dividend of €0.03 which represents an annual dividend yield of N/A. See more information on Daxor Corp dividends here
What is Daxor Corp’s EPS estimate?
Daxor Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Daxor Corp have?
Currently, no data Available
What happened to Daxor Corp’s price movement after its last earnings report?
Daxor Corp reported an EPS of €0.641 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.662%.
Which hedge fund is a major shareholder of Daxor Corp?
Currently, no hedge funds are holding shares in DE:DX5
---
Daxor Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€21.59 (142.55% Upside)
€21.59 (142.55% Upside)
Insider Transactions
Bought Shares
Worth $13.7K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.58%
12-Months-Change
Fundamentals
Return on Equity
0.89%
Trailing 12-Months
Asset Growth
15.23%
Trailing 12-Months
Company Description
Daxor Corp
Daxor Corp. is a biotechnology company which develops and manufactures BVA-100 blood volume analyzer, an instrument that measures human blood volume. Its IDANT division provides autologous blood storage; and andrology services, such as semen analysis, sperm washing and general lab testing. The company was founded by Joseph Feldschuh in 1970 and is headquartered in New York, NY.
---
DX5 Earnings Call
Q4 2023
0:00 / 0:00
---
DX5 Stock 12 Months Forecast
Average Price Target
€21.59
▲(142.55% Upside)
Technical Analysis
Best Analysts Covering DX5
1 Year
1 Year Success Rate
5/11 ratings generated profit
1 Year Average Return
-3.60%
reiterated a buy rating last month
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of -3.60% per trade.
---